US Stock MarketDetailed Quotes

EYPT EyePoint Pharmaceuticals

Watchlist
  • 8.850
  • -0.200-2.21%
Close Nov 29 13:00 ET
604.02MMarket Cap-4447P/E (TTM)

About EyePoint Pharmaceuticals Company

EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

Company Profile

SymbolEYPT
Company NameEyePoint Pharmaceuticals
Listing DateJan 27, 2005
Founded1987
CEODr. Jay S. Duker, M.D.
MarketNASDAQ
Employees121
Fiscal Year Ends12-31
Address480 Pleasant Street,Suite A-210
CityWatertown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02472
Phone1-617-926-5000
Websitehttp://www.eyepointpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jay S. Duker, M.D.
  • Director, President and Chief Executive Officer
  • 2.92M
  • Dr. Ramiro Ribeiro, M.D.,PhD
  • Chief Medical Officer
  • --
  • George O. Elston
  • Executive Vice President, Chief Financial Officer and Principal Accounting Officer
  • 1.78M
  • Nancy S. Lurker
  • Executive Vice Chairman of the Board
  • 3.74M
  • Dr. Goran A. Ando, M.D.
  • Chairman of the Board
  • 214.78K
  • Fred Hassan
  • Director
  • --
  • Dr. John B. Landis, PhD
  • Director
  • 161.67K
  • Karen Zaderej
  • Independent Director
  • 149.17K
  • Stuart M. Duty
  • Independent Director
  • 381.10K
  • Wendy F. DiCicco
  • Independent Director
  • 171.67K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data